This page lists medical journal articles discussing the association between Alzheimer’s Disease and moldy buildings.
The Health Effects of Moldy Buildings page of the Paradigm Change site provides further information on this topic.
Bredesen DE. Inhalational Alzheimer’s disease: an unrecognized – and treatable – epidemic. Aging (Albany NY). 2016 Feb;8(2):304-13. PMID: 26870879
Identifying subtypes of Alzheimer’s disease may aid in the development of therapeutics, and recently three different subtypes have been described: type 1 (inflammatory), type 2 (non-inflammatory or atrophic), and type 3 (cortical). Here it is reported that type 3 Alzheimer’s disease is the result of exposure to specific toxins, and is most commonly inhalational (IAD), a phenotypic manifestation of chronic inflammatory response syndrome (CIRS), due to biotoxins such as mycotoxins. The appropriate recognition of IAD as a potentially important pathogenetic condition in patients with cognitive decline offers the opportunity for successful treatment of a large number of patients whose current prognoses, in the absence of accurate diagnosis, are grave.
Links on this page are in orange (no underlining).